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Fecal microbiota transplant is a highly effective treatment
for refractory Clostridium difficile infection.1 Cytomega-
lovirus (CMV) colitis is often neglected in the patients with
diarrhea who are nonimmunocompromised and in intensive
care units.2,3
A 63-year-old woman had a past history of bladder
transitional cell carcinoma post-transurethral resection of
bladder tumor. She was otherwise formerly healthy but had
diarrhea for 2 weeks prior to this admission. A stool C.
difficile toxin B assay was positive. Oral metronidazole was
given with partial improvement of diarrhea. However,
bloody stool and abdominal distension developed, which
were not responsive to subsequent therapy with oral van-
comycin. On March 12, 2014, colonoscopy with biopsy
demonstrated findings compatible with pseudomembranous
colitis. Then, donor feces from her son and husband were
transplanted twice via duodenal tubing into the intestine of
the patient. Initially, the bloody stool improved. However,
abdomen distension remained and an episode of hyper-
capnic respiratory failure led to conscious disturbance. The
patient was intubated and was transferred to the intensive
care unit. At that time, the result of stool C. difficile toxin
assay became negative. Kidney, ureter, and bladder radi-
ography revealed distended intestinal loop with much
bowel gas, suggesting toxic enterocolitis (Figures 1A and.05.021
Society of Microbiology. Publishe
commons.org/licenses/by-nc-nd1B). Polymerase chain reaction (PCR) detected CMV DNA in
the patient’s blood samples. CMV immunohistochemical
stain on previous colon mucosal biopsy confirmed CMV co-
litis on March 19, 2014. Ganciclovir (200 mg once daily) was
infused intravenously and then the bowel gas was
completely resolved 3 days later (Figure 1C). After 2 weeks
of intravenous ganciclovir therapy, blood CMV-PCR became
negative on April 2, 2014. She was successfully extubated.
Oral valganciclovir was given for an additional 2 weeks. On
April 18, 2014, the follow-up colonoscopy showed complete
mucosal healing of the colitis lesions without scarring.
Random biopsies revealed chronic nonspecific colitis
without evidence of CMV infection. She was then dis-
charged uneventfully.
CMV infection can occur usually in an immunocompro-
mosed patient, but antiviral therapy may be necessary in
selected immunocompetent patients with refractory CMV
clinical symptoms.2,3 Coinfection with cytomegalovirus and
C. difficile is rarely reported in the literature and, when
present, is often a diagnostic challenge and has a high
mortality rate.3,4 CMV colitis could be concurrent with or
subsequent to the treatment for C. difficile colitis.3 As CMV
and C. difficile colitis have overlapping symptomatology,
the identification of individual pathogen as well as effec-
tive therapy may be delayed.3,4 A definitive diagnosis of
CMV colitis depends upon colonoscopic biopsy, especially
with immunohistochemical staining. However, noninvasive
methods of CMV PCR for blood and/or stool samples are
useful to screen the CMV infections.3,5
The current case highlighted a toxic enterocolitis with
distended intestinal loop and hypercapnic respiratory fail-
ure after therapy with metronidazole, vancomycin, and
fecal microbiota transplants for C. difficile infection. We
suggest blood and/or fecal PCR survey for CMV colitis in a
patient with refractory pseudomembranous colitis. Proven
CMV colitis and effective antiviral therapy might circum-
vent unnecessary fecal microbiota transplants.d by Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Figure 1. Kidney, ureter, and bladder radiography showing distended intestinal loop with much bowel gas, suggesting toxic
enterocolitis.
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